- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/404 - Indoles, e.g. pindolol
Patent holdings for IPC class A61K 31/404
Total number of patents in this class: 5350
10-year publication summary
|
308
|
323
|
340
|
332
|
312
|
319
|
326
|
343
|
365
|
297
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1627 |
98 |
| Novartis AG | 10685 |
76 |
| The Regents of the University of California | 20195 |
52 |
| Boehringer Ingelheim International GmbH | 4632 |
48 |
| The Johns Hopkins University | 5731 |
46 |
| Janssen Pharmaceuticals, Inc. | 441 |
35 |
| F. Hoffmann-La Roche AG | 7946 |
33 |
| Centre National de La Recherche Scientifique | 10632 |
31 |
| Arena Pharmaceuticals, Inc. | 362 |
31 |
| Pfizer Inc. | 3379 |
29 |
| Allergan, Inc. | 2319 |
28 |
| Katholieke Universiteit Leuven | 1207 |
28 |
| Achillion Pharmaceuticals, Inc. | 164 |
26 |
| Emory University | 1646 |
26 |
| Bristol-myers Squibb Company | 4847 |
25 |
| Generics [UK] Limited | 117 |
25 |
| The Regents of the University of Michigan | 4759 |
24 |
| Merck Sharp & Dohme LLC | 3737 |
23 |
| Takeda Pharmaceutical Company Limited | 2707 |
22 |
| Board of Regents, The University of Texas System | 5906 |
21 |
| Other owners | 4623 |